Literature DB >> 21545557

Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne.

Belinda K Lloyd1, Paul R McElwee.   

Abstract

INTRODUCTION AND AIMS: There is growing concern regarding pharmaceutical drug-related harms. Evidence suggests increasing non-medical use of pharmaceutical drugs, along with associated morbidity and mortality. This paper explores trends of pharmaceutical-related ambulance attendances over the past decade in order to identify populations experiencing acute harm, and levels of harms in the community. DESIGN AND METHODS: A retrospective analysis of pharmaceutical drug-related ambulance attendances in metropolitan Melbourne, Australia, is presented, with rates of attendances over the period 2000 to 2009 and change over time examined. Characteristics of attendances are explored to understand the nature of presentation and demographic characteristics.
RESULTS: Benzodiazepines represented the drug group with the highest rates of attendances over the 10 year period. Rates of attendances increased significantly for opioid analgesics, while significant decreases were noted for benzodiazepines, antidepressant and anticonvulsants. While women represented the majority of patients for each drug category presented over the period examined, there was an increase in the proportion of men attended in relation to opioid analgesics. Alcohol involvement in presentations has increased significantly for all drug groups. DISCUSSION AND
CONCLUSIONS: Increasing pharmaceutical-related ambulance attendances for opioid analgesics reflect increasing use, with the increase in other analgesic-related attendances also concerning. The overrepresentation of female patients reflects a population experiencing drug-related harm not reflected in illicit drug research. The rise of alcohol involvement represents heightened risk of adverse events including death, and suggests an area for public education to prevent alcohol and drug-related harms.
© 2011 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545557     DOI: 10.1111/j.1465-3362.2011.00292.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  5 in total

Review 1.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

Review 2.  Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis.

Authors:  Joanne E Brady; Rebecca Giglio; Katherine M Keyes; Charles DiMaggio; Guohua Li
Journal:  Inj Epidemiol       Date:  2017-08-07

3.  Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses.

Authors:  Desiree Madah-Amiri; Lars Myrmel; Guttorm Brattebø
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-09-22       Impact factor: 2.953

4.  Exploring Harms Experienced by Children Aged 7 to 11 Using Ambulance Attendance Data: A 6-Year Comparison with Adolescents Aged 12⁻17.

Authors:  Debbie Scott; Rose Crossin; Rowan Ogeil; Karen Smith; Dan I Lubman
Journal:  Int J Environ Res Public Health       Date:  2018-07-02       Impact factor: 3.390

5.  Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study.

Authors:  Suzanne Nielsen; Rose Crossin; Melissa Middleton; Catherine Martin; James Wilson; Tina Lam; Debbie Scott; Karen Smith; Dan Lubman
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.